| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | WZ-1-84 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.06 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | -0.09 | 0.06 |
| mRNA | Panobinostat | FIMM | pan-cancer | AAC | 0.21 | 0.06 |
| mRNA | NVP-BEZ235 | GDSC1000 | pan-cancer | AAC | -0.069 | 0.06 |
| mRNA | isoevodiamine | CTRPv2 | pan-cancer | AAC | -0.064 | 0.06 |
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | -0.068 | 0.06 |
| mRNA | SB52334 | GDSC1000 | pan-cancer | AAC | -0.066 | 0.06 |
| mRNA | Bosutinib | GDSC1000 | pan-cancer | AAC | 0.066 | 0.06 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.089 | 0.06 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | -0.059 | 0.06 |